EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism

Daniel Zaienne, Laura Isigkeit, Julian A Marschner, Silke Duensing-Kropp, Georg Höfner, Daniel Merk iD

ChemMedChem · 2023

DOI: 10.1002/cmdc.202300404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Daniel Zaienne und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany. Hauptthemen laut MEDLINE: Sesquiterpenes, Indenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinoid X receptors (RXR) are ligand‐sensing transcription factors with a unique role in nuclear receptor signaling as universal heterodimer partners. RXR modulation holds potential in cancer, neurodegeneration and metabolic diseases but adverse effects of RXR activation and lack of selective modulators prevent further exploration as therapeutic target. The natural product valerenic acid has been discovered as RXR agonist with unprecedented preference for RXR subtype and homodimer activation. To capture structural determinants of this activity profile and identify potential for optimization, we have studied effects of structural modification of the natural product on RXR modulation and identified an analogue with enhanced RXR homodimer agonism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SesquiterpenesIndenesRetinoid X ReceptorsReceptors, Cytoplasmic and Nuclear

Stichwörter der Autor:innen

cancernatural product synthesisneurodegenerationretinoid X receptortranscription factor

Substanzen

valerenic acidSesquiterpenesIndenesRetinoid X ReceptorsReceptors, Cytoplasmic and Nuclear

Autor:innen und Institutionen

  • Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany.
  • Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, 81377, Munich, Germany.

ORCID-Profile: Daniel Merk

Förderung

  • German Research Foundation
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Zaienne, D., Isigkeit, L., Marschner, J. A., Duensing-Kropp, S., Höfner, G., & Merk, D. (2023). Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism. ChemMedChem. https://doi.org/10.1002/cmdc.202300404

Vancouver

Zaienne D, Isigkeit L, Marschner JA, Duensing-Kropp S, Höfner G, Merk D. Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism. ChemMedChem. 2023. doi:10.1002/cmdc.202300404

BibTeX
@article{Zaienne2023,
  author = {Zaienne, Daniel and Isigkeit, Laura and Marschner, Julian A and Duensing-Kropp, Silke and Höfner, Georg and Merk, Daniel},
  title = {Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism},
  journal = {ChemMedChem},
  year = {2023},
  doi = {10.1002/cmdc.202300404}
}
Kostenlos starten →